address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,marketState,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChangePercent,regularMarketPrice,shortName,longName,trailingPegRatio
GustavslundsvAegen 34,Bromma,167 51,Sweden,46 8 31 14 20,https://oncozenge.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"OncoZenge AB (publ), a pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of pain in the oral cavity. The company was incorporated in 2020 and is headquartered in Bromma, Sweden.",1,"[{'maxAge': 1, 'name': 'Mr. Stian  Kildal', 'age': 48, 'title': 'Chief Executive Officer', 'yearBorn': 1976, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael  Owens B.A., B.S., B.S.B.A', 'age': 68, 'title': 'Chief Financial Officer', 'yearBorn': 1956, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ida  Sparrfeldt', 'age': 38, 'title': 'Chief Auditor', 'yearBorn': 1986, 'exercisedValue': 0, 'unexercisedValue': 0}]",[],86400,2,6.38,6.37,5.96,6.37,6.38,6.37,5.96,6.37,0.0,1.376,-30.550001,64909,64909,48350,79434,79434,6.06,6.0,74730800,3.15,12.1,27.5353,5.487,5.83,0.0,0.0,SEK,False,82338560,-2.31098,5934515,11713200,0.54837,0.1296,12230900,0.853,7.1629543,1735603200,1767139200,1743379200,-6272000,-0.52,-0.2,30.338,0.7479452,0.10500872,EQUITY,6.11,11.5,11.5,11.5,11.5,0.0,strong_buy,1,1294000,0.11,0,2.638,2.798,2714000,0.232,-0.27044,-0.47768003,2714000,-6016625,-8368000,1.0,0.0,0.01622,SEK,ONCOZ.ST,en-US,US,Equity,Delayed Quote,True,HIGH,0.62300014,0.113541126,0.2800002,0.048027482,15,0,0.0 - Strong Buy,False,False,1613116800000,-0.26999998,5.96 - 6.37,Stockholm,48350,2.96,0.93968254,3.15 - 12.1,-5.9900002,-0.49504134,74.79452,1621335540,1621335540,-0.52,-0.2,PREPRE,[],1751988579,STO,finmb_694394254,Europe/Stockholm,CEST,7200000,se_market,False,-4.2319746,6.11,OncoZenge AB,OncoZenge AB (publ),
